 Robert Langer at the Ana Lázaro Cancer Research Grant Award CeremonyThe renowned Robert Langer (MIT), one of today's most influential scientists, will be at the NOVA Medical School on 27 June at 10 a.m. for the presentation of the "Ana Lázaro - Cancer Research Grant", where he will speak on the topic "From nanotechnology to mRNA vaccines: How overcoming skepticism and barriers led to new cancer treatments and ways to tackle a global health challenge". |  Robert Langer Honoris Causa @Nova Medical SchoolProfessor Robert Langer, co-founder of Moderna and ‘Institute Professor’ at the Massachusetts Institute of Technology (MIT), was honoured with the title of Doctor Honoris Causa by the NOVA University Lisbon. He was honoured by the Vice Dean for Research at NOVA Medical School, João Conde. This recognition reinforces NOVA Medical School's commitment to innovation and scientific excellence. |  Subdiretor para a Investigação da NOVA Medical School distinguido com menção honrosa Basinnov AwardO investigador principal e subdiretor para a Investigação da NOVA Medical School, João Conde, foi recentemente distinguido com uma menção honrosa pela Basinnov Life Sciences (Grupo FHC) no âmbito do prémio Basinnov Innovation Award 2024. A entrega da menção decorreu no evento satélite da Websummit, o HealthTech Connect, no 8Marvila, em Lisboa, no dia 13 de novembro. |
---|
 Researchers develop hydrogel to treat gonorrheaA team of researchers, including members of NOVA Medical School, is developing a cationic surfactant-based hydrogel that has shown efficacy against Neisseria gonorrhoeae, the bacterium that causes gonorrhea. |  Time - COVID-19 ‘Radically’ Changed the Leading Causes of DeathCOVID-19 became the second leading cause of death globally in the year after it was declared a pandemic, according to a study published in the Lancet.
While heart disease remained the top killer, COVID “radically altered” the main five causes of death for the first time in 30 years, displacing stroke, the publication said. In 2021, 94 in every 100,000 people died from COVID, on an age-standardized basis. |  Researchers publish the largest database of nanomedicines for cancer in the leading journal in the fA group of researchers, including members of NOVA Medical School, recently published the largest database of nanomedicines for cancer using Artificial Intelligence (AI) in the largest journal in the field - Nature Nanotechnology. |
---|
 World’s Top 2% Scientists listSo happy and honored to be part of the "World’s Top 2% Scientists list" by Stanford University as scientists with the most impact in 2021. Thank you so much to all @CNanolab, NOVA Medical School - Faculdade de Ciências Médicas, Universidade Nova de Lisboa and collaborators around the world who helped make this achievement possible |  Presentation @COLife community meeting 2022the COLife Community Meeting 2022 aims to bring together directors, group leaders, postdocs, students, technicians, staff and heads of facilities and technical platforms, all members of our community, who are eager to share their experience and know-how. |  NOVA Sustainability Week 2022Round-table conversation at Universidade Nova de Lisboa in NOVA SUSTAINABILITY WEEK - Nova Medical School #NMSResearch |
---|
 Publico - Mortes por cancro subiram 20% no mundo numa década. Em Portugal foi 10%“Este aumento mundial do número de casos e de mortes é muito significativo. Dez anos é um período curto. Estes resultados são uma grande chamada de atenção para a necessidade de aumentar a prevenção em todos os tipos de cancro”, diz ao PÚBLICO João Conde, professor e investigador da Nova Medical School e um dos especialistas deste consorcio internacional, reforçando que estes retratos permitem aos governos tomar medidas que ajudem a travar o peso da doença, como o reforço de rastreios. |  Potencial Terapêutica com Nanopartículas para o Tratamento do Cancro da MamaJoão Conde, investigador principal do grupo Nanomedicina em Cancro na NOVA Medical School, publicou um estudo na revista Advanced Healthcare Materials, em que são avaliadas as potencialidades de um novo sistema terapêutico de nanopartículas para o tratamento do cancro da mama. |  CEDOC joins consortium aiming to fight inequalities in health access worldwideJoão Conde, leader of the Cancer NanoMedicine lab at CEDOC, is one of the contributors of a new The Lancet publication on Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. |
---|
 Diário de Noticias - João CondeJoão Conde, professor de Genética, investigador do Centro de Estudos de Ciências Médicas (ToxOmics), da Faculdade de Ciências Médicas, Universidade Nova de Lisboa, defende que as farmacêuticas devem apoiar a investigação e que a nanomedicina é uma aposta de futuro. |  A new meta-analysis sheds light on the progress of nanotechnology across the globeJoão Conde, from the Cancer Nanomedicine lab at CEDOC, just published a meta-analysis on the progress and investment in nanotechnology, alongside colleagues from iMed from Universidade de Lisboa and i3S from Universidade do Porto, MIT (United States of America) and University of Wollongong (Australia). The research was published on ACS Nano with the title “Facts and Figures on Materials Science and Nanotechnology Progress and Investment”. |  ERC 10 000 GranteesWhat being and ERC meant for João Conde | CEDOC-NMS |
---|
 CEDOC researchers stand out in the top 2% of the most cited authors in their fieldCEDOC researchers Miguel Seabra, principal investigator of Molecular Mechanisms of Disease group, Pedro Póvoa, from Integrated Pathophysiological Mechanisms group, and Winchil Vaz, from Lysosomes in Chronic Human Pathology and Infection group, integrate the group of the most cited scientists worldwide in different disciplines, ranking in the top 2% in their respective fields. João Conde, from Cancer Nanomedicine group, presently working at CEDOC, also integrates this list. |  Q&A Spotlight on early-career researchersNature Communications Biology - “Swallowing the doctor”: an interview with João Conde about the future of nanomedicine |  Recent Nanotechnology Applications to Combat the SARS-CoV-2 PandemicAZO NANO Editorial Feature |
---|